摘要 : The Chiesi Group of laboratories focuses on the research, development, production, and commercialization of innovative medicines in the respiratory, neonatology, rare disease, and special-care therapeutic areas. In 2009, Dr. David... 展开 The Chiesi Group of laboratories focuses on the research, development, production, and commercialization of innovative medicines in the respiratory, neonatology, rare disease, and special-care therapeutic areas. In 2009, Dr. David Lewis founded the company's Chippenham, U.K., office and tasked the researchers there to continue to develop products at the cutting edge of aerosol science, with a focus on pressurized systems. Chiesi Chippenham has invested heavily in multiple disciplines related to drug discovery. 收起